| Structure |
Chemical Name |
CAS |
MF |
 |
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
 |
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
 |
Benfotiamine |
22457-89-2 |
C19H23N4O6PS |
![3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene](http://CAS/20200611/GIF/2408302-78-1.gif) |
3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene |
2408302-78-1 |
C22H13N |
![tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate](/) |
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
 |
(3S,4S,5S)-Oseltamivir |
|
|
 |
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
 |
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
 |
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
 |
3-(3-(Trifluoromethyl)phenyl)propan-1-ol |
78573-45-2 |
C10H11F3O |
 |
(R)-ethyl thiazolidine-4-carboxylate |
|
C6H11NO2S |
 |
Ranolazine-d3 |
1054624-77-9 |
C24H33N3O4 |
 |
5-Benzylidenehydantoin |
3775-01-7 |
C10H8N2O2 |
![5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester](/CAS/GIF/147125-14-2.gif) |
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
 |
Clopidogrel camphorsulfonate |
120202-68-8 |
C26H32ClNO6S2 |
![(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)](/CAS/GIF/130793-28-1.gif) |
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |
130793-28-1 |
C29H55NO6 |
 |
1-Phenyl-3-(2-hydroxyethyl)thiourea |
102-12-5 |
C9H12N2OS |
 |
NA |
58500-79-1 |
C6Fe2O6S2 |
 |
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
 |
RET-IN-1 |
2222755-14-6 |
C29H31N9O3 |
![1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)-](/CAS/20200331/GIF/1403902-78-2.gif) |
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
 |
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
 |
Dimethyl 4-aminothiophene-2,3-dicarboxylate hydrochloride |
121071-71-4 |
C8H10ClNO4S |
 |
((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol hydrochloride |
2416218-32-9 |
C8H14FNO.ClH |
![(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol](/CAS/GIF/150-05-0.gif) |
(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol |
150-05-0 |
C9H13NO3 |
 |
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
![5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester](/CAS/20211123/GIF/1847464-89-4.gif) |
5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847464-89-4 |
C29H35N7O5 |
![Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)-](/CAS/20210305/GIF/2145122-45-6.gif) |
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
 |
4-MAR |
|
|
 |
27-Demethyl Rifampicin |
|
|
 |
Sunitinib Malate E-Isomer |
|
|
 |
Δ3-Ceftiofur |
|
|
![2-Propenamide, N-[2-(phosphonooxy)ethyl]-](/CAS/20210305/GIF/146222-14-2.gif) |
2-Propenamide, N-[2-(phosphonooxy)ethyl]- |
146222-14-2 |
C5H10NO5P |
 |
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
 |
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
![(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide](/CAS/20210305/GIF/2209874-02-0.gif) |
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
 |
20-hydroxy Prostaglandin F2a |
|
|
![1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)-](/CAS/20210305/GIF/2209874-17-7.gif) |
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
 |
Methyl 5-amino-2,4-difluorobenzoate |
125568-73-2 |
C8H7F2NO2 |
 |
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
 |
CALCIUM PIDOLATE |
31377-05-6 |
C10H12CaN2O6 |
 |
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
 |
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
 |
Chloropretadalafil |
171489-59-1 |
C22H19ClN2O5 |
![5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide](/CAS/GIF/89729-09-9.gif) |
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
 |
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
 |
3-FLUOROINDOLE |
66946-81-4 |
C8H6FN |
 |
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |
 |
N4-Acetyl-2'-O-Methyl-cytidine |
113886-71-8 |
C12H17N3O6 |
![5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine](/CAS2/GIF/1010120-55-4.gif) |
5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine |
1010120-55-4 |
C6H5BrN4 |
 |
Cis-(1s,3s)-3-(2-methoxyphenyl)cyclobutan-1-amine hydrochloride |
|
|
 |
4,4'-Dibromo-2,2'-diiodobiphenyl |
852138-89-7 |
C12H6Br2I2 |
 |
Sterolazole intermediate |
|
|
 |
2',3'-Anhydroinosine |
31766-13-9 |
C10H10N4O4 |
![2-(4-aminobicyclo[2.2.1]heptan-1-yl)acetonitrile hydrochloride](/CAS/20250703/GIF/2230282-21-8.gif) |
2-(4-aminobicyclo[2.2.1]heptan-1-yl)acetonitrile hydrochloride |
2230282-21-8 |
C9H14N2.ClH |
![1-[2-(Dimethylamino)ethyl]-1H-tetrazole-5-thiol](/CAS/GIF/61607-68-9.gif) |
1-[2-(Dimethylamino)ethyl]-1H-tetrazole-5-thiol |
61607-68-9 |
C5H11N5S |
 |
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL |
913742-54-8 |
C11H20N2O4.ClH |
 |
NS 1738 |
501684-93-1 |
C14H9Cl2F3N2O2 |
![Ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate](/CAS/GIF/926663-00-5.gif) |
Ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate |
926663-00-5 |
C9H9N3O3 |
 |
(3R,4R,5S)-4-N-Acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester monohydrochloride |
651324-08-2 |
C26H45ClN2O4 |
 |
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
 |
5-Hydroxy-3,4-dihydroquinolin-2(1H)-one |
30389-33-4 |
C9H9NO2 |
 |
SalbutaMol DiMer |
149222-15-1 |
C26H40N2O5 |
![[2S-[2α(R*),3β]]-N-ForMyl-](/CAS/GIF/104872-28-8.gif) |
[2S-[2α(R*),3β]]-N-ForMyl- |
104872-28-8 |
C29H53NO5 |
 |
7-DesMethylagoMelatine |
152302-45-9 |
C14H15NO2 |
 |
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
899809-64-4 |
C9H11NO4 |
 |
Aegelin |
456-12-2 |
C18H19NO3 |
 |
1,2,4-cyclohexanetricarboxylic anhydride |
53611-01-1 |
C9H10O5 |
 |
3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate |
104680-25-3 |
C10H13NO4S |
![N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride](/CAS/20150408/GIF/1260590-51-9.gif) |
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
1260590-51-9 |
C13H19N5.ClH |
![tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate](/CAS/20150408/GIF/1172623-99-2.gif) |
tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbaMate |
1172623-99-2 |
C16H21F2NO4 |
 |
N,N-Diphenyl-1H-imidazole-1-carboxamide |
2875-79-8 |
C16H13N3O |
 |
Coumarin |
10172-76-6 |
C27H21NO6 |
 |
Pemetrexed intermediate |
|
|
 |
R-Avanafil |
1638497-26-3 |
C23H26ClN7O3 |
 |
(2S,5S)-ethyl 5-methylpyrrolidine-2-carboxylate 2,2,2-
trifluoro acetate salt |
676560-85-3 |
C10H16F3NO4 |
 |
,100kg |
180048-73-1 |
C11H14O4S |
 |
Berberine Impurity 13 |
55971-02-3 |
C20H16NO4.Cl |
 |
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
 |
Thionicotinamide |
4621-66-3 |
C6H6N2S |
 |
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
![1-([(9H-Fluoren-9-ylmethoxy)carbonyl]amino)-3,3-difluorocyclobutane-1-carboxylic acid](/CAS/20200331/GIF/1936532-04-5.gif) |
1-([(9H-Fluoren-9-ylmethoxy)carbonyl]amino)-3,3-difluorocyclobutane-1-carboxylic acid |
1936532-04-5 |
C20H17F2NO4 |
 |
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
 |
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
![(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate](/CAS/20211123/GIF/1428484-17-6.gif) |
(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate |
1428484-17-6 |
C36H51F5O4S |
 |
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
 |
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
 |
2’-deoxyinosine |
|
|
 |
Anti-Ceftriaxong |
|
|
 |
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
 |
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
 |
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
 |
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
 |
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
 |
Biapenem Impurity A Dimer |
|
|
 |
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
 |
3-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID |
68208-20-8 |
C9H10ClNO2 |
 |
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
 |
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
 |
5-Mercapto-1H-tetrazole-1-methane sulphonic acid |
67146-22-9 |
C2H4N4O3S2 |